Many intracellular and secreted signaling molecules are synthesized as precursors that undergo elaborate post-translational processing events critical to their normal and pathological functions. To better understand these events, we are studying the biogenesis of the Saccharomyces cerevisiae mating pheromone a-factor, an extracellular signaling peptide that is prenylated and carboxyl methylated. Mature a-factor is derived from a precursor that terminates with a CaaX motif (""""""""C"""""""" is Cys, """"""""a"""""""" is aliphatic, """"""""X"""""""" is any of several residues). The biogenesis of the a-factor precursor is distinctive, involving: (1) C-terminal (CaaX) processing (by the farnesyl transferase Ram1p/Ram2p, the endoproteases Ste24p and Rcelp, and the methyltransferase Ste14p), (2) N-terminal proteolytic cleavage (by the endoproteases Ste24p and Axllp), and (3) a non-classical export mechanism (mediated by the a-factor exporter, Ste6p). We have recently shown that one of these components, Ste24p, is a multispanning membrane protein with intrinsic protease activity that acts in dual steps of a-factor biogenesis, mediating both C- and N-terminal processing. Furthermore, in extending our studies to mammalian systems we discovered a new mammalian Ste24p substrate, prelamin A (the nuclear lamin A precursor). In this proposal we will focus on the activity, topology, and interaction of the membrane-associated a-factor CaaX processing components (Ste24p, Rcelp, Ste14p) and explore the possibility that these proteins (and others) may form a CaaX processing """"""""machine"""""""" (Aims 1-3). CaaX processing renders a-factor extremely lipophilic; yet to exit the cell a-factor must transit through the aqueous environment of the cytosol, and thereafter must diffuse through the extracellular milieu. We will examine the trafficking of a-factor, both inside and outside of the cell, and genetically identify novel factors involved in these processes (Aims 4-6). Essentially all of the steps in a-factor biogenesis are mediated by multispanning membrane proteins. Therefore in the long-term, our studies will lead to a better fundamental understanding of the structure, function, catalytic properties, and organization of multispanning membrane proteins that mediate diverse cellular processes, extending beyond a-factor biogenesis. Such processes include the proteolytic processing events that generate the cholesterol biosynthesis regulator (SREBP), the Alzheimer's precursor protein (APP), and mammalian prelamin A (defects in which result in human laminopathies). Our studies also bear on the development of chemotherapeutic agents designed to inhibit the CaaX processing of oncogenic Ras proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM041223-12
Application #
6739324
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Chin, Jean
Project Start
1988-12-01
Project End
2007-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
12
Fiscal Year
2004
Total Cost
$323,730
Indirect Cost
Name
Johns Hopkins University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Worman, Howard J; Michaelis, Susan (2018) Permanently Farnesylated Prelamin A, Progeria, and Atherosclerosis. Circulation 138:283-286
Spear, Eric D; Hsu, Erh-Ting; Nie, Laiyin et al. (2018) ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability. Dis Model Mech 11:
Ast, Tslil; Michaelis, Susan; Schuldiner, Maya (2016) The Protease Ste24 Clears Clogged Translocons. Cell 164:103-114
Mehmood, Shahid; Marcoux, Julien; Gault, Joseph et al. (2016) Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24. Nat Chem 8:1152-1158
Kane, Megan S; Lindsay, Mark E; Judge, Daniel P et al. (2013) LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset. Am J Med Genet A 161A:1599-611
Michaelis, Susan; Hrycyna, Christine A (2013) Biochemistry. A protease for the ages. Science 339:1529-30
Barrowman, Jemima; Wiley, Patricia A; Hudon-Miller, Sarah E et al. (2012) Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity. Hum Mol Genet 21:4084-93
Michaelis, Susan; Barrowman, Jemima (2012) Biogenesis of the Saccharomyces cerevisiae pheromone a-factor, from yeast mating to human disease. Microbiol Mol Biol Rev 76:626-51
Barrowman, Jemima; Hamblet, Corinne; Kane, Megan S et al. (2012) Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24. PLoS One 7:e32120
Barrowman, Jemima; Bhandari, Deepali; Reinisch, Karin et al. (2010) TRAPP complexes in membrane traffic: convergence through a common Rab. Nat Rev Mol Cell Biol 11:759-63

Showing the most recent 10 out of 36 publications